Leerink Swann Equities Analysts Lift Earnings Estimates for UnitedHealth Group Inc. (UNH)
UnitedHealth Group Inc. (NYSE:UNH) – Stock analysts at Leerink Swann lifted their Q3 2016 earnings per share (EPS) estimates for shares of UnitedHealth Group in a research note issued on Monday. Leerink Swann analyst A. Gupte now anticipates that the brokerage will post earnings per share of $2.10 for the quarter, up from their prior forecast of $2.07. Leerink Swann currently has a “Outperform” rating on the stock. Leerink Swann also issued estimates for UnitedHealth Group’s Q4 2016 earnings at $2.10 EPS.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 18th. The healthcare conglomerate reported $2.17 earnings per share for the quarter, topping analysts’ consensus estimates of $2.08 by $0.09. The company earned $46.30 billion during the quarter, compared to analysts’ expectations of $46.09 billion. UnitedHealth Group had a return on equity of 19.08% and a net margin of 3.51%. UnitedHealth Group’s quarterly revenue was up 11.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.77 EPS.
A number of other analysts have also recently weighed in on the company. Sanford C. Bernstein restated an “outperform” rating and issued a $178.00 price target on shares of UnitedHealth Group in a research note on Tuesday, September 6th. Royal Bank Of Canada raised their price target on UnitedHealth Group from $157.00 to $165.00 and gave the company an “outperform” rating in a research note on Wednesday, July 20th. Vetr upgraded UnitedHealth Group from a “buy” rating to a “buy” rating in a research note on Friday, October 7th. Credit Suisse Group AG restated a “buy” rating and issued a $148.00 price target on shares of UnitedHealth Group in a research note on Wednesday, June 29th. Finally, Zacks Investment Research cut UnitedHealth Group from a “hold” rating to a “sell” rating in a research note on Monday, July 18th. Two equities research analysts have rated the stock with a hold rating, twenty-four have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $155.28.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/19/leerink-swann-equities-analysts-lift-earnings-estimates-for-unitedhealth-group-inc-unh.html
UnitedHealth Group (NYSE:UNH) traded up 1.59% during trading on Wednesday, reaching $145.67. The company had a trading volume of 2,551,462 shares. The stock has a market capitalization of $138.73 billion, a price-to-earnings ratio of 22.80 and a beta of 0.57. UnitedHealth Group has a 1-year low of $107.51 and a 1-year high of $145.74. The firm has a 50-day moving average of $137.12 and a 200-day moving average of $136.75.
Several large investors have recently bought and sold shares of the company. Van Hulzen Asset Management LLC acquired a new stake in UnitedHealth Group during the second quarter valued at about $104,000. Archford Capital Strategies LLC boosted its stake in UnitedHealth Group by 669.2% in the second quarter. Archford Capital Strategies LLC now owns 800 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 696 shares during the period. Hanson McClain Inc. boosted its stake in UnitedHealth Group by 0.4% in the second quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock valued at $126,000 after buying an additional 4 shares during the period. Howe & Rusling Inc. boosted its stake in UnitedHealth Group by 4.5% in the second quarter. Howe & Rusling Inc. now owns 920 shares of the healthcare conglomerate’s stock valued at $130,000 after buying an additional 40 shares during the period. Finally, Parkside Financial Bank & Trust boosted its stake in UnitedHealth Group by 31.4% in the second quarter. Parkside Financial Bank & Trust now owns 996 shares of the healthcare conglomerate’s stock valued at $140,000 after buying an additional 238 shares during the period. Institutional investors and hedge funds own 85.80% of the company’s stock.
In other news, Director Richard T. Burke sold 40,000 shares of the firm’s stock in a transaction on Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the sale, the director now owns 2,003,550 shares in the company, valued at $271,100,350.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.65% of the company’s stock.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th were issued a dividend of $0.625 per share. This represents a $2.50 annualized dividend and a dividend yield of 1.74%. The ex-dividend date of this dividend was Tuesday, September 6th. UnitedHealth Group’s dividend payout ratio (DPR) is 39.12%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.